| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 13,709 | 13,368 | 14,139 | 18,266 | | Cost of Revenue | 7,283 | 7,310 | 7,468 | 9,763 | | | Gross Profit | 6,426 | 6,058 | 6,671 | 8,503 | | | Operating Expenses | | Research Development | 2,673 | 2,649 | 2,688 | 2,589 | | Selling General and Administrative | 4,014 | 4,456 | 4,616 | 4,699 | | Non Recurring | 1 | 339 | 1,639 | 16,524 | | Others | 554 | 553 | 553 | 518 | | | | Total Operating Expenses | 7,242 | 7,997 | 9,496 | 24,330 | | | | Operating Income or Loss | (10,452) | 7,443 | (2,625) | (15,827) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 376 | (53) | 365 | (1,472) | | Earnings Before Interest And Taxes | (440) | (1,992) | (2,460) | (17,299) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (440) | (1,992) | (2,460) | (17,299) | | Income Tax Expense | 315 | (700) | (596) | (6,545) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (755) | (1,292) | (1,864) | (10,754) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 103 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (755) | (1,292) | (1,864) | (10,651) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($755) | ($1,292) | ($1,864) | ($10,651) |
|
0.51% Nasdaq 
Income Statement
